NGS completes Sprout deal and puts founder at the helm

Sprout acquisition changes NGS operating profile

Nutritional Growth Solutions Ltd (ASX:NGS) has completed its acquisition of Sprout Organic and its logistics subsidiary Better Brands 3PL, turning what was previously an acquisition strategy into the company’s new operating base. Sprout founder Selasi Berdie has taken the top job as CEO and executive director, with the combined group spanning infant formula, toddler nutrition, children’s products, snacks and third-party logistics.

The transaction was approved by shareholders on 10 August. NGS issued 401.2 million consideration shares at a deemed A$0.02 each, alongside shares converting founder loans and convertible notes. After the allotments, shares on issue reached 964.0 million, giving the deal a substantial equity component and materially changing the company’s capital structure.

Five major Sprout shareholders have agreed to voluntary escrow covering 331.8 million consideration shares for 12 months, until 30 September 2027. The escrow does not remove dilution, but it limits the immediate availability of a sizeable portion of the newly issued consideration stock.

Founder takes control as management team resets

Berdie will lead the combined business on a base salary of A$200,000 plus superannuation. His proposed package also includes 60 million performance rights in six tranches, with vesting tied to share price and financial performance milestones between 30 June 2027 and 31 December 2028. Those rights still require shareholder approval, and the detailed milestones are yet to be put to investors.

Joel Dening has joined as chief operating officer after 14 years at sports nutrition brand BSc, where he rose to global commercial director. Manik Pujara, who guided NGS as interim CEO through the transaction, has moved to a non-executive director role. Guy Khavia has resigned from the board, while Ben Chester will not take up the previously foreshadowed COO appointment.

Unaudited figures point to a near break-even platform

The investor presentation reports combined revenue of A$5.11 million for January to August 2026, based on unaudited management accounts and pro forma inclusion of Sprout and Better Brands 3PL before completion. Normalised EBITDA was a loss of A$190,000, while normalised gross margin stood at 34%. August revenue of A$720,000 was the highest monthly result in the period.

NGS says it has identified A$870,000 in annualised savings from shared corporate functions, lower listing and director costs and back-office consolidation, with most actions taken at completion. The calculation is a management estimate rather than reported post-acquisition earnings, so the next combined-group accounts will matter more than the headline saving itself.

Cross-selling plan carries the next test

Management’s pitch is that the brands fill different stages of childhood and can use each other’s channels. Sprout brings an organic, plant-based formula range sold through more than 1,000 stores and export markets, while Healthy Heights targets children aged three and over and has published clinical studies behind its growth nutrition products. The integration plan includes taking Healthy Heights into Sprout’s Australian pharmacy network and using NGS’s US e-commerce infrastructure to expand Sprout’s toddler, children’s and snack ranges.

NGS also plans to progress distribution in Vietnam and Chile, launch US-specific stock keeping units and establish North American warehousing. US sales of Sprout infant formula remain subject to Food and Drug Administration requirements, and the timing of the expansion is described as indicative rather than fixed.

Capital structure leaves execution little room for error

The company raised A$2.5 million at A$0.02 a share before completion, with A$1.6 million retained for integration, inventory and working capital after transaction-related payments. At the same reference price, the presentation values the enlarged equity base at about A$19.3 million, although that is not a market trading valuation and the group also has options outstanding that take fully diluted securities to approximately 1.12 billion.

The strategic logic is now clear, but the financial proof is still ahead. NGS must show that the promised savings flow through, that inventory converts into sales and that the two brands can share distribution without diluting their separate propositions. The September 2026 quarterly report is the first scheduled opportunity to see the acquisition on the group’s actual cash and operating statements.